Search For "bharat biotech"
Updated : 3 weeks, 4 days ago IST
New Delhi [India], May 26 (ANI): COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Septembe
Updated : 3 weeks, 5 days ago IST
New Delhi [India], May 24 (ANI): Bharat Biotech is confident about obtaining the World Health Organization's (WHO) Emergency Use Listing for its COVID-19 vaccine given its experience of getting its other vaccines pre-qualified and has submitted 90 per cent of the documentation required for E
Updated : 3 weeks, 6 days ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
Updated : 1 month ago IST
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Bengaluru (Karnataka) [India], May 16 (ANI): Amid the rising COVID-19 cases in Karnataka, locals in Bengaluru say that they have been facing a lot of difficulties in getting the COVAXIN vaccine.
New Delhi [India], May 16 (ANI): Vaccination with Bharat Biotech's COVID-19 vaccine - COVAXIN, has produced neutralising titres (concentration) against all key emerging variants tested, including the B.1.617 and B.1.1.7, first identified in India and the United Kingdom, the vaccine manufa
Bengaluru (Karnataka) [India], May 14 (ANI): Karnataka will soon have a manufacturing plant of Bharat Biotech's Covaxin in Maluru industrial area, near Kolara district, said Deputy Chief Minister and State COVID task force head Dr C N Ashwatha Narayana on Friday.
Updated : 1 month, 1 week ago IST
New Delhi [India], May 13 (ANI): Delhi Health Minister Satyendar Jain on Thursday said that he has suggested to the Union Health Ministry that the Central government should float a single global tender instead of various states to purchase COVID-19 vaccines.
New Delhi [India], May 13 (ANI): Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursday.
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.